Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Chemotherapy|Breast Cancer, Metastatic
Interventions: DRUG: Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)
Sponsor: HaEmek Medical Center, Israel